Cargando…
A highly-sensitive anti-Müllerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer()
AIM: Anti-Müllerian hormone (AMH) shows promise as a biomarker of the ovarian reserve but current assays are insufficiently sensitive to allow assessment of this post-chemotherapy in most women. We have assessed a new highly sensitive AMH assay (Ansh picoAMH) in the evaluation of ovarian activity in...
Autores principales: | Chai, Joyce, Howie, A. Forbes, Cameron, David A., Anderson, Richard A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166459/ https://www.ncbi.nlm.nih.gov/pubmed/25027307 http://dx.doi.org/10.1016/j.ejca.2014.06.011 |
Ejemplares similares
-
Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer()
por: Anderson, Richard A., et al.
Publicado: (2013) -
The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer
por: Anderson, R.A., et al.
Publicado: (2017) -
Diagnostic and predictive accuracy of anti-mullerian hormone for ovarian function after chemotherapy in premenopausal women with early breast cancer
por: Anderson, Richard A., et al.
Publicado: (2022) -
Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function
por: Moolhuijsen, Loes M E, et al.
Publicado: (2020) -
Post-chemotherapy serum anti-Müllerian hormone level predicts ovarian function recovery
por: Kim, Hyun-Ah, et al.
Publicado: (2018)